Lantheus Holdings, Inc. Finite-Lived Intangible Assets, Translation Adjustments (Deprecated 2016-01-31)
Lantheus Holdings, Inc. (LNTH) reported Finite-Lived Intangible Assets, Translation Adjustments (Deprecated 2016-01-31) of -$1.45 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-02.
Discontinued › Notes › Intangible Assets
us-gaap:FiniteLivedIntangibleAssetsTranslationAdjustments · last filed 2016-03-02
- Lantheus Holdings, Inc. finite-lived intangible assets, translation adjustments (deprecated 2016-01-31) for fiscal 2015 was -$1.45M.
- Lantheus Holdings, Inc. finite-lived intangible assets, translation adjustments (deprecated 2016-01-31) for fiscal 2014 was -$925.00K.
| Period end | Finite-Lived Intangible Assets, Translation Adjustments (Deprecated 2016-01-31) 12 month |
|---|---|
| 2015-12-31 | -$1.45M 10-K · filed 2016-03-02 |
| 2014-12-31 | -$925.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |